Pentam 300 (APP Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Pentam 300 drug offered from APP Pharmaceuticals, LLC. This Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | APP Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | PENTAMIDINE ISETHIONATE |
SUBSTANCE NAME: | PENTAMIDINE ISETHIONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiprotozoal [EPC] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-01-16 |
END MARKETING DATE: | 0000-00-00 |
Pentam 300 HUMAN PRESCRIPTION DRUG Details:
Item Description | Pentam 300 from APP Pharmaceuticals, LLC |
LABELER NAME: | APP Pharmaceuticals, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/3mL) |
START MARKETING DATE: | 2001-01-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-113_2cd3bffe-b3ad-4a79-b782-6880ee48afb0 |
PRODUCT NDC: | 63323-113 |
APPLICATION NUMBER: | NDA019264 |
Other PENTAMIDINE ISETHIONATE Pharmaceutical Manufacturers / Labelers: